Regis Healthcare CEO Exit: What Investors Watch Next
Regis Healthcare (ASX: REG) shares fell 2.6% to A$7.13 after CEO Dr Linda Mellors announced her resignation to pursue a career opportunity in a different industry. The departure ends a six-year tenure that transformed Regis Healthcare from a struggling business into one of the ASX's best-performing healthcare…
Can AI predict future stock returns? Some might say yes, and even that artificial intelligence can outperform human analysts. Certainly, used together, humans and AI are particularly difficult to beat.
Machine learning is a field of research focused on developing methods that analyse data and improve performance without direct human intervention. It is a core component…
Investing in ASX-listed casino stocks demands a unique blend of market analysis and sector-specific insight. It is a high-stakes game where understanding volatility is as crucial as spotting growth potential. For instance, while retail investors may research a platform like Lucky Hills casino login to understand consumer trends, the real investment play requires deeper scrutiny…
The financial world moves faster than most bankers can keep up with. AI, quantum computers, blockchain - these aren't buzzwords anymore. The world's largest banks are dumping billions into these technologies because whoever figures them out first gets to set the rules for the next decade.
What are the Best Financial stocks to invest in right…
Arafura Rare Earths (ASX: ARU) presents one of the most puzzling setups on the ASX right now. The company has locked in over A$1.35 billion in sovereign-backed funding from the US, Canada, Germany, and Australia, yet shares trade around A$0.25, down sharply from the October high of A$0.62. For investors watching the critical minerals space,…
Commercial momentum builds as Mesoblast targets two major 2026 catalysts: Adult label expansion and Revascor BLA filing.
Mesoblast (ASX: MSB) closed at A$2.91 last Friday, up 27% over the past month as investors position ahead of the company's expected US$30 million-plus Q2 revenue report. The share price is now close to its January high of…
TechnologyOne (ASX: TNE) has finally put one of Australia's longest-running employment disputes behind it. The Federal Court threw out a former manager's A$54.7 million claim late last week, clearing the Brisbane-based software company completely. For investors, this removes a legal cloud that has hung over the stock since 2016. But with shares trading around A$28.35,…
Austal (ASX: ASB) locked in more than A$1.16 billion in new contracts last week, cementing its position as Australia's go-to defence shipbuilder. The centrepiece is a A$1.029 billion deal to design and build 18 Landing Craft Medium vessels for the Australian Army. This was followed by a contract valued at over A$135 million for two…
Develop Global (ASX: DVP) climbed 4% to A$4.36 on Friday after securing a A$200 million underground development contract with global gold producer OceanaGold. The timing is notable: just one day after OceanaGold received final approval under the New Zealand Government’s Fast-track Approvals Act for its Waihi North Project, Develop locked in one of the largest…
Nova Minerals (ASX: NVA) dropped nearly 14 per cent to A$0.90 following the announcement of a US$20 million (approximately AUD 30.2 million) capital raise on the Nasdaq. The offering, priced at US$6.83 per American Depositary Share, will issue approximately 35.14 million new ordinary shares (representing 2.93 million ADSs) to fund exploration and development at the…
